Trials / Recruiting
RecruitingNCT07461519
Gonadic Function and Pubertal Development in Female Patients With Classic Galactosemia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Newborn screening and a galactose-free diet have improved early outcomes in galactosemia, but long-term issues such as primary ovarian insufficiency (POI) remain significant. This study aims to clarify clinical, hormonal, developmental, and fertility-related factors in affected girls through a large multicenter Italian cohort.
Detailed description
Newborn screening for galactosemia and adherence to a galactose-free diet have greatly reduced acute neonatal symptoms, leading to high survival rates. However, despite good therapeutic compliance, long-term complications-especially primary ovarian insufficiency (POI) and its related morbidity-remain common. Because galactosemia is rare, identifying factors underlying ovarian dysfunction and fertility-preservation options has been challenging. A large, homogeneous multicenter Italian study could help clarify unresolved aspects of POI in females with classic galactosemia. Primary aims: * Compare clinical, auxological, and hormonal features of girls with galactosemia to those of the general population at key stages of pubertal development. * Identify potential factors contributing to POI. * Describe fertility-related characteristics in affected patients. Secondary aims: * Determine the proportion of patients who reach their familial height target. * Assess quality of life and psycho-emotional adjustment. * Evaluate psychomotor and cognitive development.
Conditions
Timeline
- Start date
- 2025-02-12
- Primary completion
- 2042-02-28
- Completion
- 2042-08-31
- First posted
- 2026-03-10
- Last updated
- 2026-03-10
Locations
19 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT07461519. Inclusion in this directory is not an endorsement.